Cargando…
The P2 promoter of the IGF1 gene is a major epigenetic locus for GH responsiveness
Short children using growth hormone (GH) to accelerate their growth respond to this treatment with a variable efficacy. The causes of this individual variability are multifactorial and could involve epigenetics. Quantifying the impact of epigenetic variation on response to treatments is an emerging...
Autores principales: | Ouni, M, Belot, M P, Castell, A L, Fradin, D, Bougnères, P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746489/ https://www.ncbi.nlm.nih.gov/pubmed/25869012 http://dx.doi.org/10.1038/tpj.2015.26 |
Ejemplares similares
-
The IGF1 P2 promoter is an epigenetic QTL for circulating IGF1 and human growth
por: Ouni, Meriem, et al.
Publicado: (2015) -
Genetic and Epigenetic Modulation of Growth Hormone Sensitivity Studied With the IGF-1 Generation Test
por: Ouni, Meriem, et al.
Publicado: (2015) -
Fetal growth is associated with CpG methylation in the P2 promoter of the IGF1 gene
por: Le Stunff, Catherine, et al.
Publicado: (2018) -
Correction to: Fetal growth is associated with CpG methylation in the P2 promoter of the IGF1 gene
por: Le Stunff, Catherine, et al.
Publicado: (2018) -
T2DM: Why Epigenetics?
por: Fradin, Delphine, et al.
Publicado: (2011)